Skip to content
Search

Latest Stories

PSNC urge pharmacy contractor to follow procedures for unplanned temporary closures

The Pharmaceutical Services Negotiating Committee (PSNC) has urged the pharmacy contractors to follow appropriate procedures for unplanned temporary closures due to current workforce pressure, to avoid a breach of terms of service.

“If the temporary closure is not for reasons beyond the contractor’s control, this may be a breach of the terms of service,” said PSNC.


The committee also informed that in some areas, NHS England regional teams may ask contractors to complete a new notification form for any temporary closures that request more information than the standard form, for example, on the mitigating actions taken by the contractor.

It added: “Completion of these forms is voluntary but may help to show NHS England that the closure was for reasons beyond the contractor’s control, or that the overall circumstances of the closure, including time closed and steps taken to ensure patient and public needs are met, indicate that there is no public interest in taking any regulatory/performance action (such as a breach notice) against the contractor.”

The procedures – as well as closing the premises and restricting entry/access – include the following:

  1. Notifying NHS England as soon as practical: There is an unplanned temporary suspension of services notification form which contractors should complete to notify NHS England of the temporary closure and the reasons for it.
  2. Updating the Directory of Services (DoS) and NHS website entries: Using NHS Profile Manager, contractors must update their DoS and the NHS website entries to ensure that they provide accurate information of the pharmacy’s opening hours to patients, the public, and other relevant NHS service providers.
  3. Trying to re-open the pharmacy: Contractors must use all reasonable endeavours to re-open and provide NHS pharmacy services as soon as practicable.
  4. Making alternative arrangements for the provision of NHS pharmacy services: Contractors must, where practicable, make alternative arrangements with one or more pharmacies in the area, for the ongoing provision of NHS pharmacy services.

Alternative arrangements for the ongoing provision of NHS pharmacy services are likely to include:

  1. Clinical: Identifying any urgent prescriptions which are awaiting dispensing, collection or delivery, such as those for antibiotics or analgesics, and making arrangements for the ongoing supply of medicines prescribed by installment prescriptions or supplied in monitored dosage systems. It is important that staff do as much as they can before they leave the premises to ensure patients are able to access their prescriptions.
  2. Information: Displaying clear notices advising patients and the public of the closure, including any arrangements for accessing their medicines and the estimated time when the pharmacy will re-open, and providing relevant information to those with, for example, urgent prescriptions.
  3. GPs: Informing local GP practices of the situation and any arrangements made with local pharmacies while the pharmacy is closed.

The committee is working with NHS England and the Department of Health and Social Care, as indicated in the CPCF Years 4 and 5 letter to contractors, to consider what can be done to relieve the current pressures contractors are facing.

More For You

DHSC announces second list of March 2025 price concessions

A price concession only applies for the month it is granted.

Getty Images

March price concessions list released; prescription charge remains unchanged

The Department of Health and Social Care (DHSC) has released a second list of price concessions for March 2025, following ongoing discussions with Community Pharmacy England (CPE) regarding medicine pricing concerns raised by pharmacy owners.

A price concession is introduced when pharmacy contractors are unable to source a drug at or below the reimbursement price set out in the Drug Tariff.

Keep ReadingShow less
AstraZeneca partners with CEPI to develop multi-specific influenza antibody

AstraZeneca-CEPI collaboration aims to increase global access to antibody-based interventions

Getty Images

AstraZeneca secures £33M CEPI funding to develop multi-specific influenza antibody

AstraZeneca has joined forces with the Coalition for Epidemic Preparedness Innovations (CEPI) to advance an innovative antibody technology that could help tackle future infectious disease outbreaks and pandemics swiftly and more affordably.

CEPI will provide up to US$43.5 million (£33.6 million) in funding to support the biopharmaceutical company in evaluating a type of antibody, known as a VHH (Variable Heavy domain of a Heavy chain -only antibody), through preclinical proof-of-concept studies and Phase 1 clinical trials.

Keep ReadingShow less
Community Pharmacy Patient Safety Group announces new vice-chair

Martin Sadr-Kazemi 's appointment follows the passing of Dr. José Moss in January 2025.

Martin Sadr-Kazemi appointed vice-chair of Community Pharmacy Patient Safety Group

The Community Pharmacy Patient Safety Group (CPPSG) has announced the appointment of Martin Sadr-Kazemi as its new vice-chair.

Martin, currently the medication safety officer and deputy superintendent pharmacist at Rowlands Pharmacy, has been an integral member of the CPPSG since its formation a decade ago, actively contributing to various initiatives.

Keep ReadingShow less
"My work benefits all across London," says ambulance pharmacy technician

Mahrukh Jaffar

Pic credit: London Ambulance Service

"My work benefits all across London," says ambulance pharmacy technician

Mahrukh Jaffar will create history when she becomes the first apprentice to become a qualified pharmacy technician through the London Ambulance Service.

Jaffar is just days away from completing her registration with the General Pharmaceutical Council.

Keep ReadingShow less
Independent economic analysis will not be published before contract announcement, says NHSE

Pharmacy minister Stephen Kinnock

Independent economic analysis will not be published before contract announcement, says NHSE


The independent economic analysis of pharmacy finances will not be published before a new funding contract has been announced despite calls for the immediate release of the review.

Keep ReadingShow less